NCT04112732

Brief Summary

Investigation of the chronic effect of 12 week multivitamin supplementation on markers of everyday function in adults aged 70 and over.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
228

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 2, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

November 24, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
Last Updated

July 29, 2025

Status Verified

December 1, 2022

Enrollment Period

1.9 years

First QC Date

August 30, 2019

Last Update Submit

July 24, 2025

Conditions

Keywords

MultivitaminAgingStressEveryday FunctionWell-Being

Outcome Measures

Primary Outcomes (1)

  • Overall Well-Being (change from baseline)

    An overall outcome measure which is a composite measure made up of four personal well-being questions used in the Measuring National Well-being programme plus one additional question. These five questions are: 1. Overall, how satisfied are you with your life nowadays? 2. Overall, to what extent do you feel the things you do in your life are worthwhile? 3. Overall, how happy did you feel yesterday? 4. Overall, how anxious did you feel yesterday? 5. Overall, how well did you feel yesterday?

    Measured at baseline and then following chronic (12 weeks) treatment

Secondary Outcomes (26)

  • Cardiovascular reactivity- Blood pressure (change from baseline)

    Measured at baseline and then following chronic (12 weeks) treatment

  • Cardiovascular reactivity- Heart rate (change from baseline)

    Measured at baseline and then following chronic (12 weeks) treatment

  • Immune/inflammatory response (change from baseline)

    Measured at baseline and then following chronic (12 weeks) treatment

  • Immune/inflammatory response(change from baseline)

    Measured at baseline and then following chronic (12 weeks) treatment

  • Self-Reported Stress (change from baseline)

    Measured at baseline and then following chronic (12 weeks) treatment

  • +21 more secondary outcomes

Study Arms (2)

Multivitamin

EXPERIMENTAL

1 multivitamin tablet administered by mouth daily for 12 weeks, to be taken with main meal.

Dietary Supplement: Multivitamin

Placebo

PLACEBO COMPARATOR

1 placebo tablet administered by mouth daily for 12 weeks, to be taken with main meal.

Other: Placebo

Interventions

MultivitaminDIETARY_SUPPLEMENT

Multivitamin

Multivitamin
PlaceboOTHER

Placebo

Placebo

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Aged over 70
  • Both caregivers and non caregivers will be recrtuied

You may not qualify if:

  • Allergy to soya
  • Participants must not be currently taking the investigational product (or another equivalent multivitamin); any participants who report multivitamin use must be willing to have a washout for 4 weeks before participating (if not willing to do this they will be excluded)
  • If a participant has epilepsy, a thyroid disorder, haemochromatosis or suffers from food allergies they must consult their doctor/pharmacist before taking part

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northumbria University

Newcastle upon Tyne, NE1 8ST, United Kingdom

Location

MeSH Terms

Interventions

Geritol

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 30, 2019

First Posted

October 2, 2019

Study Start

November 24, 2019

Primary Completion

September 30, 2021

Study Completion

September 30, 2021

Last Updated

July 29, 2025

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations